Lv2
180 积分 2021-10-22 加入
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
3天前
已完结
Targeting CDH17 with Chimeric Antigen Receptor-Redirected T Cells in Small Cell Lung Cancer
1个月前
已完结
CAR-T cell therapy: Challenge and opportunity for effective treatment of small cell lung cancer
1个月前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
3个月前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
3个月前
已完结
B7-H3-targeted CAR-T cell therapy for solid tumors
3个月前
已完结
Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors
4个月前
已完结
Harnessing Natural Killer Immunity in Metastatic SCLC
6个月前
已完结
Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective
7个月前
已完结
The role of immunotherapy in small cell lung cancer
7个月前
已完结
皖公网安备34019202002308
